BARROW NEUROLOGICAL INSTITUTE
🇺🇸United States
Speech Analysis in ALS Patients
Completed
- Conditions
- First Posted Date
- 2019-03-11
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Barrow Neurological Institute
- Target Recruit Count
- 26
- Registration Number
- NCT03868345
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
Deep Phenotyping in Patients With ALS
Completed
- Conditions
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2021-12-16
- Lead Sponsor
- Barrow Neurological Institute
- Target Recruit Count
- 32
- Registration Number
- NCT02819765
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸Hospital for Special Surgery (HSS), New York, New York, United States
🇺🇸Spectrum Health, Grand Rapids, Michigan, United States
A Trial of Tocilizumab in ALS Subjects
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- Barrow Neurological Institute
- Target Recruit Count
- 22
- Registration Number
- NCT02469896
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-09-10
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Barrow Neurological Institute
- Target Recruit Count
- 52
- Registration Number
- NCT01938495
- Locations
- 🇺🇸
St Louis University, Saint Louis, Missouri, United States
🇺🇸Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸Stanford University, Stanford, California, United States
© Copyright 2024. All Rights Reserved by MedPath